Mallinckrodt to Report Earnings Results for First Quarter 2023

Rhea-AI Summary

Mallinckrodt plc (NYSE: MNK), a global specialty pharmaceutical company, will announce its first quarter 2023 earnings results on May 9, 2023. The earnings release will cover the financial period ending March 31, 2023. Investors can participate in a conference call scheduled for 8:30 a.m. ET on the same day. Mallinckrodt's operations include the development and distribution of specialty pharmaceutical products focusing on autoimmune and rare diseases, as well as specialty generics.

For further details, investors can access the call registration and audio webcast links provided in the press release. The company is committed to providing timely information through its website.

Positive

• Upcoming earnings release for Q1 2023 may show financial growth.
• Focus on specialty pharmaceuticals, particularly in high-demand therapeutic areas.

Negative

• Earnings results are pending, introducing uncertainty about financial performance.

DUBLIN, April 24, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that it will report first quarter 2023 earnings results for the period ended March 31, 2023, on Tuesday, May 9, 2023. 

A conference call for investors will begin at 8:30 a.m. ET. The call can be accessed as follows:

• Live Call Participant Registration (including dial-in): https://register.vevent.com/register/BIbe1f9805fe5b4490acd8359f7bdd616d
• Audio Only Webcast Link (live and replay):
• https://edge.media-server.com/mmc/p/24fqexpx
• At the Mallinckrodt website: https://ir.mallinckrodt.com/

ABOUT MALLINCKRODT 
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The Company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com.

Mallinckrodt uses its website as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. It also uses its website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the U.S. Securities and Exchange Commission (SEC) disclosing the same information. Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. Visitors to the website can also register to receive automatic e-mail and other notifications alerting them when new information is made available on the Investor Relations page of the website.

CONTACTS

Investor Relations
Daniel Speciale
Global Corporate Controller & Chief Investor Relations Officer
314-654-3638
daniel.speciale@mnk.com

Derek Belz
Vice President, Investor Relations
314-654-3950
derek.belz@mnk.com

Media
Michael Freitag / Aaron Palash / Aura Reinhard
Joele Frank, Wilkinson Brimmer Katcher
212-355-4449

Mallinckrodt, the "M" brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. © 2023 04/23.

View original content to download multimedia:https://www.prnewswire.com/news-releases/mallinckrodt-to-report-earnings-results-for-first-quarter-2023-301805210.html

SOURCE Mallinckrodt plc

FAQ

When will Mallinckrodt report its first quarter 2023 earnings results?

Mallinckrodt will report its first quarter 2023 earnings results on May 9, 2023.

What time is the Mallinckrodt earnings call scheduled?

The Mallinckrodt earnings call is scheduled for 8:30 a.m. ET on May 9, 2023.

How can I access the Mallinckrodt earnings call?

Investors can register for the call and access it through links provided in the press release.

What is Mallinckrodt's stock ticker symbol?

Mallinckrodt's stock ticker symbol is MNK.